Mativ (MATV) Q4 2025 earnings review
Transformation Takes Hold: FAM Recovers, Cash Flow Surges
Mativ delivered a pivotal quarter, proving its turnaround thesis is gaining traction. While top-line growth remains modest (+1.0% YoY), operational improvements drove a 19% surge in Adjusted EBITDA and a 180bps margin expansion. The previously struggling FAM segment reversed course to become the growth driver (+5.6% Sales), while the steady SAS segment stumbled slightly. Crucially, the company generated record full-year Free Cash Flow of $93.8M—up 139% YoY—validating the deleveraging narrative. Note: GAAP Net Income of $100.8M is heavily distorted by a $111M tax valuation allowance benefit; Adjusted EPS of $0.15 reflects the true operating reality (vs $0.05 in 24Q4).
🐂 Bull Case
Filtration & Advanced Materials (FAM) has officially turned the corner. After quarters of drag, FAM sales rose 5.6% YoY and Adjusted EBITDA surged 26%, driven by favorable price-cost dynamics and volume mix. It is now contributing to growth rather than offsetting it.
Full-year Free Cash Flow hit a record $93.8M, more than doubling FY24 levels ($39.2M). This provides critical ammunition for debt reduction, addressing the primary bear thesis of leverage overhang.
🐻 Bear Case
Sustainable & Adhesive Solutions (SAS), the reliable growth engine throughout FY25, hit a wall in Q4. Sales fell 1.7% reported (organic -0.3%), breaking a multi-quarter streak of organic growth (e.g., +5% in Q3), due to lower volume/mix.
Management explicitly flagged an 'environment of anemic market demand.' Total organic growth is barely positive (+1.9%), relying heavily on cost outs and pricing rather than robust volume demand.
⚖️ Verdict: 🟢
Bullish. The quality of earnings has improved dramatically. The successful turnaround of the FAM segment combined with record cash flow generation outweighs the momentary pause in SAS growth. Mativ is executing well on controllable factors (margins, costs) in a soft market.
Key Themes
FAM Segment: From Laggard to Leader
Reversing. For the first time in recent quarters, FAM outperformed SAS. Sales grew 5.6% YoY to $177.2M, and Adjusted EBITDA jumped 26.2% to $33.2M. Margin expanded 300bps to 18.7%. This validates the strategic initiatives and stabilizes the business leg that had been crushed by destocking in prior periods.
Operational Leverage & Cost Discipline
Accelerating. Adjusted EBITDA margin expanded 180bps YoY to 11.6%. Management cited 'disciplined commercial operational execution' and 'favorable price versus input cost.' Even with modest top-line help, the company is squeezing significantly more profit out of every dollar of sales.
SAS Organic Growth Reversal
Decelerating. SAS Organic growth turned negative (-0.3%) in Q4 after posting +5.2% in Q3 and +5.0% in Q2. While EBITDA margin improved slightly (+130bps), the volume/mix decline suggests customer demand in tapes/labels may be softening or facing stiffer comps.
Tax Benefit Distortion
The GAAP Net Income of $100.8M includes a massive $111M tax benefit from a decrease in valuation allowance. Investors must ignore the GAAP EPS of $1.80 and focus on the Adjusted EPS of $0.15 to understand true operating cadence. However, the release of the valuation allowance signals management confidence in future taxable income generation.
Macro Headwinds Persist
Stable (Negative). CEO Shruti Singhal noted the company is navigating 'anemic market demand.' While Mativ is winning on self-help measures (price/cost, mix), they are not getting help from the broader economy. This puts a ceiling on revenue growth until the macro environment improves.
Other KPIs
Accelerating. Up significantly from $0.05 in the prior year period (24Q4). Full year Adj EPS landed at $0.70 vs $0.62 in FY24, showing resilience despite the challenging H1.
Improving. Decreased from $995.0M at the end of 2024. The strong FCF generation is being directly applied to the balance sheet, reducing risk.
Accelerating. Up 139% vs $39.2M in FY24. This record cash generation is the standout metric of the report, driven by inventory management and EBITDA growth.
Guidance
Management did not provide specific numeric ranges for Revenue or EBITDA in the press release text. They expressed general confidence: 'Excited for our path ahead in 2026' and focused on 'future profitable growth.'
Key Questions
SAS Volume Weakness
SAS organic growth flipped to -0.3% after three consecutive quarters of ~5% growth. Is this a one-quarter blip due to timing/destocking, or a signal of weakening end-market demand in packaging/adhesives?
FAM Margin Sustainability
FAM EBITDA margins jumped to 18.7% from ~15.7%. How much of this is structural cost improvement vs. temporary mix benefits or timing of input costs?
Capital Allocation with Record FCF
With record FCF of ~$94M and leverage reducing, will 2026 see an acceleration of share repurchases, or is the priority solely further debt reduction given the 'anemic' demand environment?